Consumer groups slam J&J and Allergan over lack of post-market research for breast implants
This article was originally published in Clinica
Executive Summary
Johnson & Johnson has been criticised by the US FDA and consumer groups after its Mentor subsidiary failed to carry out the appropriate post-marketing studies for its silicone breast implants. Some non-profit organisations have even urged the FDA to take the drastic step of rescinding its approval of the implants.